Irritable Bowel Syndrome News

Researchers observed that dietary fermentable oligosaccharides, disaccharides and monosaccharides and polyols — or FODMAPs — were linked to symptoms of irritable bowel syndrome and variations in the metabolome, according to results from a controlled, single blind study.

Data from a literature review demonstrate that despite the numerous studies performed worldwide to ascertain irritable bowel syndrome prevalence among adults, study methodologies are not uniform, leaving clinicians with a lack of reliable global prevalence data.

Migraine and tension headaches may have genetic links in common with irritable bowel syndrome, according to results from a preliminary study released in advance of the American Academy of Neurology’s 68th Annual Meeting in Vancouver, Canada.

Visceral sensitivity and severity of irritable bowel syndrome may be determined with the use of a nutrient and lactulose challenge test. The results of the test may also help characterize patients with IBS and help determine the efficacy of treatments.

ExeGi Pharma has launched Visbiome and Visbiome Extra Strength, new probiotic formulations comparable to VSL#3 that relieve symptoms associated with ulcerative colitis, chronic pouchitis, irritable bowel syndrome and other GI conditions, according to a press release.

A comprehensive self-management program designed to improve quality of life and reduce symptoms in patients with irritable bowel syndrome resulted in sustained changes in behavior after 1 year, according to new research data.

Viberzi safely and effectively reduced symptoms of irritable bowel syndrome with diarrhea, according to the results of two phase 3 trials.

SYN-010, a microbiome-based therapy in development for patients with irritable bowel syndrome with constipation, significantly reduced methane production and improved other symptoms in its second phase 2 clinical trial, the manufacturer announced.

Ebastine, a histamine receptor H1 antagonist, was found to reduce visceral hypersensitivity, symptoms and abdominal pain in patients with irritable bowel syndrome in a recent study.

A dietitian-directed gluten-free diet was found to be beneficial for patients with irritable bowel syndrome with diarrhea when studied in patients who had not previously considered a gluten-free diet. The negative or positive human leukocyte antigen (HLA) allele DQ2/8 genotype of each patient affected which symptoms improved.